Latest News for Atlas Salt Stock (OTC:REMRF)

Atlas Salt Inc is engaged in advancing Great Atlantic Salt Project through feasibility and into potential production as an environmentally friendly state-of-the-art Salt Factory in resource-friendly western Newfoundland. It is also producing gypsum mines, nepheline discovery, and renewable energy storage.

Atlas Salt Inc

News

WISH

ContextLogic Announces Stockholder Approval Of Transaction With Qoo10

JP Morgan analyst Andrew Steinerman maintains Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Overweight and lowers the price target from $290 to $273.

Price Target

Analyst Ratings

JP Morgan Maintains Overweight on Equifax, Lowers Price Target to $273

Guidance

BDRX

Biodexa Pharmaceuticals Sees Prelim. FY23 EPS £(0.02)

The cryptocurrency market experienced a wave of mixed signals on Thursday, with Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38312737/bitcoin-defies-165m-etf-outflows-bounces-above-62-000">spot exchange-traded funds</a> (ETFs) registering net outflows while geopolitical tensions flared.
What Happened: According to <a href="https://sosovalue.xyz/assets/etf">data</a> from SoSoValue, Bitcoin spot ETFs saw a total net outflow of $4.38 million on Thursday. 
This movement reflects investor sentiment within these regulated investment vehicles, which offer a more traditional way to gain exposure to Bitcoin.
Grayscale&#8217;s Bitcoin Investment Trust (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GBTC#OTC">GBTC</a>), the world&#8217;s largest Bitcoin fund, witnessed a significant net outflow of $89.99 million. This adds to GBTC&#8217;s historical net outflow, which now stands at a substantial $16.68 billion.
However, the market also saw positive inflows into other Bitcoin spot ETFs. 
Fidelity&#8216;s Fidelity Wise Origin Bitcoin Fund (BATS:<a class="ticker" href="https://www.benzinga.com/stock/FBTC#BATS">FBTC</a>) recorded the highest net inflow for the day, attracting $37.39 million. 
BlackRock&#8216;s iShares Bitcoin Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBIT#NASDAQ">IBIT</a>) ETF also saw inflows of $18.76 million. 
These contrasting flows highlight the diverse investment strategies within the Bitcoin ETF landscape.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/digital-assets/ "><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/27091545/Benzinga-conference.gif" alt="Benzinga future of digital assets conference" class="wp-image-267246" /></a></figure>
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38321951/what-happens-after-the-bitcoin-halving">What Happens After The Bitcoin Halving?</a>
Why It Matters: The mixed ETF flows coincided with rising geopolitical tensions. 
<a href="https://edition.cnn.com/middleeast/live-news/israel-hamas-war-gaza-news-04-18-24/index.html">News</a> of an Israeli attack on Iran sent shockwaves through the market, causing both Bitcoin and Ethereum to briefly fall below key support levels. 
Bitcoin dipped below $60,000, while Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) dropped under $2,900.
It&#8217;s worth noting that despite the price drop, the amount of leverage liquidated was relatively modest. Both cryptocurrencies swiftly shook off the price dip, with Bitcoin rebounding to $65,300 and Ethereum to $3,100.
What&#8217;s Next: The interplay between geopolitical events, investor sentiment, and on-chain activity paints a complex picture for the cryptocurrency market. 
Investors seeking to navigate these uncertainties and gain insights into the evolving ETF landscape can benefit from attending Benzinga&#8217;s <a href="https://www.benzinga.com/events/digital-assets/agenda/">Future of Digital Assets</a> conference on Nov. 19.
Read Next: <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38319562/how-the-bitcoin-halving-could-impact-your-investment">How The Bitcoin Halving Could Impact Your Investment</a>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$ETH

Fidelity Wise Origin Bitcoin Fund Fidelity Wise Origin Bitcoin Fund

FBTC

GBTC

IBIT

Bitcoin Rebounds To $65K, Shakes Off $4M ETF Outflow And Geopolitical Uncertainty

The layoffs announced by&nbsp;Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) this week included&nbsp;the elimination of&nbsp;<a target="_blank" href="https://www.benzinga.com/markets/equities/24/04/38250432/elon-musks-top-deputy-made-difficult-decision-to-move-on-from-tesla-as-ev-maker-said-to-be-layin" rel="noreferrer noopener">several top managerial positions</a>, reportedly tightening CEO&nbsp;Elon Musk&#8216;s grip over the electric vehicle maker.
What Happened: According to a <a href="https://www.theinformation.com/articles/musks-tighter-grip-at-tesla-comes-with-more-direct-reports" target="_blank" rel="noreferrer noopener">report</a> by Information, at least 35 executives now directly report to Musk following the removal of two of his direct reports, Andrew Baglino and Rohan Patel, as part of the job cuts. 
The newly added executives include key figures overseeing energy, public policy, and business development, as well as the head of sales for North America and a senior content specialist, Viv Hantusch, who manages Tesla&#8217;s account on X. 
Additionally, global sales teams, previously under the leadership of&nbsp;Tom Zhu&nbsp;since his promotion last April, have now been placed back under Musk&#8217;s oversight.
Commenting on the report,&nbsp;Bob Sutton, a professor of management science at&nbsp;Stanford University School of Engineering&nbsp;and organizational psychologist, expressed concerns.&nbsp;
&#8220;A recipe for CEO overload and being a bottleneck,&#8221; he said. &#8220;This MIGHT work for CEOs who delegate, trust underlines, create psych safety, and have a strong shared culture and agreement on strategy. That Elon?&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Elon Musk now has 35 direct reports at Tesla. A recipe for CEO overload and being a bottleneck. This MIGHT work for CEOs who delegate, trust underlines, create psych safety, and have a strong shared culture and agreement on strategy. That Elon? <a href="https://t.co/EypWPF7XD9">https://t.co/EypWPF7XD9</a>
&mdash; Bob Sutton (@work_matters) <a href="https://twitter.com/work_matters/status/1781040478957494507?ref_src=twsrc%5Etfw">April 18, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also:&nbsp;<a target="_blank" href="https://www.benzinga.com/money/everything-you-need-to-know-about-tesla-stock" rel="noreferrer noopener">Everything You Need To Know About Tesla Stock</a>.
Why It&#8217;s Important: The development comes when Tesla stakeholders are unduly worried about Musk&#8217;s full involvement in his flagship EV business. This is flagged as a key risk as to why institutional ownership in Tesla is relatively less vis-a-vis other mega-cap stocks. 
Musk is also at the helm of his space venture SpaceX, the Boring company, which is an infrastructure and tunnel construction service, and Neuralink, which is engaged in the manufacturing of implantable brain-computer interfaces. His late-2022 purchase of social-media platform Twitter, which he has since then renamed X, also takes much of his time, given it is finding it difficult to rake in advertising dollars. 
As Sutton said Musk&#8217;s leadership style is exacting. His biographer Walter Isaacson described his management style as one characterized by a hands-on approach, often described as &#8220;nano-management,&#8221; where he involves himself deeply in the details of his companies.
The additional burden on Musk comes at a time when Tesla is facing a host of fundamental issues, which has pushed its stock down to its lowest level in over a year.
Check out more of Benzinga&#8217;s Future Of Mobility coverage by <a href="http://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38309306/legal-expert-says-tesla-shareholder-vote-to-approve-elon-musks-pay-for-his-past-wor">Legal Expert Says Tesla Shareholder Vote To Approve Elon Musk&#8217;s Pay &#8216;For His Past Work&#8217; Is Like Setting &#8216;Assets On Fire Without Benefit To Company&#8217;</a>
Photo via Shutterstock

Equities

Management

Tech

Media

TSLA

Management Expert Warns Elon Musk Faces 'CEO Overload' After Tesla Layoffs Reportedly Leave Him Overseeing 35 Key Personnel

Intuitive Surgical Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) reported better-than-expected results for its <a href="https://www.benzinga.com/news/earnings/24/04/38325095/intuitive-surgical-q1-earnings-revenue-beat-eps-beat-surgical-system-installed-base-up-14-and-more">first quarter on Thursday</a>.
Intuitive Surgical reported first-quarter revenue of $1.89 billion, which beat the consensus estimate of $1.87 billion, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. The robotic-assisted surgery company's top-line results were up 11% on a year-over-year basis. Intuitive Surgical reported quarterly adjusted earnings of $1.50 per share, which beat analyst estimates of $1.41 per share.
Intuitive Surgical's da Vinci surgical system installed base totaled 8,887 systems as of March 31, up 14% on a year-over-year basis. The company ended the quarter with $7.32 billion in cash, equivalents and investments.
"The core measures of our business remained healthy this quarter, as we reached meaningful milestones across several parts of our business," said Gary Guthart, CEO of Intuitive Surgical. "We are pleased by feedback from our measured da Vinci 5 launch as well as the continued adoption of SP and Ion, and we remain focused on delivering the goals we share with our customers, including improving patient outcomes."
Intuitive Surgical shares fell 0.4% to close at $372.63 on Thursday.
These analysts made changes to their price targets on Intuitive Surgical following earnings announcement.
<ul>
<li>Baird cut the price target on Intuitive Surgical from $440 to $436. Baird analyst Mike Polark maintained an Outperform rating.</li>
<li>Jefferies raised the price target on Intuitive Surgical from $365 to $375. Jefferies analyst David Windley maintained a Hold rating.</li>
</ul>

Read More: <a href="https://www.benzinga.com/news/earnings/24/04/38329059/netflix-procter-gamble-and-3-stocks-to-watch-heading-into-friday">Netflix, Procter &amp; Gamble And 3 Stocks To Watch Heading Into Friday</a>

Earnings

Trading Ideas

ISRG

These Analysts Revise Their Forecasts On Intuitive Surgical Following Q1 Results

Biodexa Pharmaceuticals Says We Have The Resources To Deliver Two Sets Of Preclinical Data And Three Sets Of Clinical Data In 2024; Our Development Pipeline Now Includes Five Programs, Of Which Four Are At Clinical Stage; With Pipeline Stronger Than It Has Ever Been, We Are Enthusiastic About The Potential For Our Company In 2024 And Beyond.

Vail Resorts Says Season-To-Date Total Skier Visits Were Down 7.8% YoY; Says Expects To Finish Year At Or Around Low End Of Resort Reported EBITDA Guidance Range Issued On March 11, 2024

JP Morgan analyst Andrew Steinerman maintains ManpowerGroup (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAN#NYSE">MAN</a>) with a Neutral and raises the price target from $82 to $84.

JP Morgan Maintains Neutral on ManpowerGroup, Raises Price Target to $84

<h3>Gainers</h3>
<ul>
<li>Asset Entities (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASST#NASDAQ">ASST</a>) stock increased by 11.8% to $0.45 during Friday's pre-market session. The company's market cap stands at $6.7 million. </li>
<li>TuanChe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TC#NASDAQ">TC</a>) shares rose 10.15% to $2.06. The company's market cap stands at $4.1 million. </li>
<li>Paramount Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PARA#NASDAQ">PARA</a>) shares moved upwards by 9.02% to $11.96. The market value of their outstanding shares is at $7.8 billion. </li>
<li>Lytus Technologies Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYT#NASDAQ">LYT</a>) stock moved upwards by 8.93% to $4.39. The market value of their outstanding shares is at $6.8 million. </li>
<li>Onfolio Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONFO#NASDAQ">ONFO</a>) stock moved upwards by 7.47% to $0.49. The company's market cap stands at $2.5 million. </li>
<li>Starbox Group Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STBX#NASDAQ">STBX</a>) stock moved upwards by 6.08% to $0.22. The market value of their outstanding shares is at $24.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>MediaCo Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDIA#NASDAQ">MDIA</a>) stock decreased by 9.2% to $2.47 during Friday's pre-market session. The company's market cap stands at $64.2 million. </li>
<li>Hanryu Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HRYU#NASDAQ">HRYU</a>) stock fell 6.6% to $0.55. The company's market cap stands at $29.0 million. </li>
<li>Global Mofy Metaverse (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GMM#NASDAQ">GMM</a>) stock declined by 6.57% to $0.82. The market value of their outstanding shares is at $23.4 million. </li>
<li>Baosheng Media Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BAOS#NASDAQ">BAOS</a>) shares declined by 6.38% to $3.17. The market value of their outstanding shares is at $4.8 million. </li>
<li>Netflix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) stock declined by 6.32% to $572.0. The company's market cap stands at $247.5 billion. As per the news, the Q1 earnings report came out yesterday. </li>
<li>Chicken Soup for the Soul (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSSE#NASDAQ">CSSE</a>) stock decreased by 4.93% to $0.14. The market value of their outstanding shares is at $4.3 million. 
See Also: <a href="http://www.benzinga.com/money/best-communication-services-stocks/" title="www.benzinga.com/money/best-communication-services-stocks/">www.benzinga.com/money/best-communication-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

ASST

BAOS

CSSE

HRYU

MDIA

NFLX

ONFO

PARA

STBX

12 Communication Services Stocks Moving In Friday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Chromocell Therapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CHRO#AMEX">CHRO</a>) stock increased by 21.6% to $1.49 during Friday's pre-market session. The company's market cap stands at $8.7 million. </li>
<li>Kineta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KA#NASDAQ">KA</a>) stock moved upwards by 16.62% to $0.57. The market value of their outstanding shares is at $6.2 million. </li>
<li>Portage Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRTG#NASDAQ">PRTG</a>) shares moved upwards by 14.83% to $0.28. The company's market cap stands at $5.4 million. </li>
<li>Erasca (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ERAS#NASDAQ">ERAS</a>) stock rose 13.73% to $2.04. The company's market cap stands at $308.4 million. </li>
<li>MSP Recovery (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIFW#NASDAQ">LIFW</a>) shares moved upwards by 13.25% to $0.94. The company's market cap stands at $14.9 million. As per the press release, Q4 earnings came out 4 days ago. </li>
<li>Cue Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLTH#NASDAQ">HLTH</a>) stock moved upwards by 12.25% to $0.16. The market value of their outstanding shares is at $25.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Nexalin Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXL#NASDAQ">NXL</a>) stock fell 18.4% to $1.2 during Friday's pre-market session. The company's market cap stands at $8.9 million. </li>
<li>iSpecimen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISPC#NASDAQ">ISPC</a>) stock decreased by 13.31% to $0.36. The market value of their outstanding shares is at $3.3 million. </li>
<li>INVO Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INVO#NASDAQ">INVO</a>) stock decreased by 11.85% to $1.34. The company's market cap stands at $3.6 million. As per the news, the Q4 earnings report came out 3 days ago. </li>
<li>Intelligent Bio Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INBS#NASDAQ">INBS</a>) stock fell 10.72% to $2.5. The company's market cap stands at $7.1 million. </li>
<li>Trevena (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRVN#NASDAQ">TRVN</a>) stock decreased by 10.39% to $0.33. The company's market cap stands at $6.0 million. </li>
<li>PaxMedica (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PXMD#NASDAQ">PXMD</a>) stock fell 9.58% to $0.69. The market value of their outstanding shares is at $5.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CHRO

ERAS

HLTH

Intelligent Bio Solutions Inc. - Common Stock

INBS

INVO

ISPC

LIFW

PRTG

PXMD

TRVN

12 Health Care Stocks Moving In Friday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>WANG &amp; LEE Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WLGS#NASDAQ">WLGS</a>) stock moved upwards by 24.0% to $0.62 during Friday's pre-market session. The market value of their outstanding shares is at $9.3 million. </li>
<li>Ault Alliance (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AULT#AMEX">AULT</a>) shares rose 21.52% to $0.29. The company's market cap stands at $8.8 million. </li>
<li>Richtech Robotics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RR#NASDAQ">RR</a>) shares rose 20.14% to $1.61. The company's market cap stands at $106.6 million. </li>
<li>Jayud Global Logistics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JYD#NASDAQ">JYD</a>) shares moved upwards by 9.19% to $0.95. The market value of their outstanding shares is at $20.2 million. </li>
<li>Simpple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPPL#NASDAQ">SPPL</a>) stock rose 7.53% to $0.7. The market value of their outstanding shares is at $11.3 million. </li>
<li>Freight Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRGT#NASDAQ">FRGT</a>) stock moved upwards by 6.67% to $0.98. The company's market cap stands at $2.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Tritium DCFC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DCFC#NASDAQ">DCFC</a>) shares fell 65.7% to $1.2 during Friday's pre-market session. The company's market cap stands at $1.2 million. </li>
<li>BioNexus Gene Lab (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGLC#NASDAQ">BGLC</a>) shares fell 22.24% to $0.66. The market value of their outstanding shares is at $11.6 million. </li>
<li>Smart Powerr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CREG#NASDAQ">CREG</a>) shares fell 8.35% to $1.1. The market value of their outstanding shares is at $8.7 million. </li>
<li>C3is (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CISS#NASDAQ">CISS</a>) stock decreased by 6.21% to $1.36. The company's market cap stands at $2.6 million. </li>
<li>Fusion Fuel Green (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTOO#NASDAQ">HTOO</a>) stock fell 6.07% to $1.23. The company's market cap stands at $23.8 million. </li>
<li>ClearSign Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLIR#NASDAQ">CLIR</a>) stock fell 5.83% to $0.81. The company's market cap stands at $31.6 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AULT

BGLC

CISS

CLIR

CREG

DCFC

FRGT

HTOO

SPPL

WLGS

12 Industrials Stocks Moving In Friday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>UTime (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTO#NASDAQ">WTO</a>) stock moved upwards by 12.6% to $0.26 during Friday's pre-market session. The company's market cap stands at $3.5 million. </li>
<li>AEye (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIDR#NASDAQ">LIDR</a>) stock rose 10.78% to $1.13. The company's market cap stands at $7.3 million. </li>
<li>BIT Mining (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTCM#NYSE">BTCM</a>) stock increased by 8.96% to $2.31. The market value of their outstanding shares is at $25.6 million. </li>
<li>Movano (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOVE#NASDAQ">MOVE</a>) stock rose 7.35% to $0.52. The market value of their outstanding shares is at $51.0 million. </li>
<li>Box (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOX#NYSE">BOX</a>) shares moved upwards by 5.78% to $28.0. The market value of their outstanding shares is at $4.0 billion. </li>
<li>Taoping (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TAOP#NASDAQ">TAOP</a>) stock increased by 5.54% to $1.14. The company's market cap stands at $2.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Bit Origin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTOG#NASDAQ">BTOG</a>) stock fell 15.8% to $2.51 during Friday's pre-market session. The market value of their outstanding shares is at $15.8 million. </li>
<li>VIA optronics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VIAO#NYSE">VIAO</a>) shares declined by 14.07% to $0.28. The market value of their outstanding shares is at $6.2 million. </li>
<li>MariaDB (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRDB#NYSE">MRDB</a>) shares decreased by 13.46% to $0.36. The company's market cap stands at $24.6 million. </li>
<li>ICZOOM Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IZM#NASDAQ">IZM</a>) stock fell 11.71% to $4.15. The company's market cap stands at $43.0 million. </li>
<li>Spectaire Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPEC#NASDAQ">SPEC</a>) stock fell 9.42% to $0.56. The company's market cap stands at $9.4 million. </li>
<li>Marin Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRIN#NASDAQ">MRIN</a>) shares fell 8.81% to $2.87. The company's market cap stands at $8.6 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BTCM

BTOG

LIDR

MOVE

MRDB

MRIN

SPEC

TAOP

VIAO

12 Information Technology Stocks Moving In Friday's Pre-Market Session

Biodexa Pharmaceuticals Sees Prelim. FY23 Revenue £0.38M

Norfolk Southern Says Ancora Alternatives LLC's Near-Term Targets Are 'highly unrealistic'; Urges Shareholders For Vote For Co.'s Nominees

JP Morgan analyst Kenneth Worthington maintains Blackstone (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BX#NYSE">BX</a>) with a Neutral and lowers the price target from $105 to $100.

JP Morgan Maintains Neutral on Blackstone, Lowers Price Target to $100

Lakeland Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LBAI#NASDAQ">LBAI</a>) reported quarterly earnings of $0.30 per share which beat the analyst consensus estimate of $0.27 by 11.11 percent. This is unchanged from the same period last year. The company reported quarterly sales of $67.65 million which missed the analyst consensus estimate of $69.61 million by 2.81 percent. This is a 17.69 percent decrease over sales of $82.19 million the same period last year.

LBAI

Lakeland Bancorp Q1 EPS $0.30 Beats $0.27 Estimate, Sales $67.65M Miss $69.61M Estimate

Biotech

General

SBFM

Sunshine Biopharma's Nora Pharma Receives Health Canada Approval For Niopeg

Argus Research analyst Marie Ferguson downgrades Crown Castle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCI#NYSE">CCI</a>) from Buy to Hold.

Downgrades

Argus Research Downgrades Crown Castle to Hold

Ratings for Inspire Medical Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INSP#NYSE">INSP</a>) were provided by 7 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $267.57, a high estimate of $285.00, and a low estimate of $250.00. This upward trend is evident, with the current average reflecting a 8.47% increase from the previous average price target of $246.67.
<img src="https://www.benzinga.com/files/images/story/2024/1713528107_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
A comprehensive examination of how financial experts perceive Inspire Medical Systems is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Shagun Singh</td>
<td>RBC Capital</td>
<td>Announces</td>
<td>Outperform</td>
<td>$285.00</td>
<td>-</td>
</tr>
<tr>
<td>Anthony Petrone</td>
<td>Mizuho</td>
<td>Maintains</td>
<td>Buy</td>
<td>$250.00</td>
<td>$250.00</td>
</tr>
<tr>
<td>Richard Newitter</td>
<td>Truist Securities</td>
<td>Maintains</td>
<td>Buy</td>
<td>$280.00</td>
<td>-</td>
</tr>
<tr>
<td>Kallum Titchmarsh</td>
<td>Morgan Stanley</td>
<td>Announces</td>
<td>Overweight</td>
<td>$250.00</td>
<td>-</td>
</tr>
<tr>
<td>Richard Newitter</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$280.00</td>
<td>$265.00</td>
</tr>
<tr>
<td>Anthony Petrone</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Buy</td>
<td>$250.00</td>
<td>$225.00</td>
</tr>
<tr>
<td>Brett Fishbin</td>
<td>Keybanc</td>
<td>Announces</td>
<td>Overweight</td>
<td>$278.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Inspire Medical Systems. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Inspire Medical Systems compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Inspire Medical Systems's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of Inspire Medical Systems's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/INSP/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Inspire Medical Systems analyst ratings.</a>
<h2>About Inspire Medical Systems</h2>
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
<h3>Inspire Medical Systems: Delving into Financials</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Inspire Medical Systems displayed positive results in 3 months. As of 31 December, 2023, the company achieved a solid revenue growth rate of approximately 39.6%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Health Care sector.
Net Margin: Inspire Medical Systems's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 7.67%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Inspire Medical Systems's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 2.64%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Inspire Medical Systems's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 2.24% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: With a below-average debt-to-equity ratio of 0.04, Inspire Medical Systems adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>What Are Analyst Ratings?</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

INSP

The Latest Analyst Ratings For Inspire Medical Systems

Atlas Salt narrows its CEO search

These Basic Materials stocks are trading higher:-Amyris Inc (AMRS) stock is trading at $1.05, an increase of $0.16, or 16.34%, on low volume.  Amyris Inc gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Buy with a price target of $1.68.  -Benson Hill Inc (BHIL)

Basic Materials Stocks Making Moves Thursday: AMRS, BHIL, FUL, EVA, REMRF, TMC, ICL, ASTLW

These Basic Materials stocks are trading higher:-Posco Holdings Inc (PKX) stock is trading at $124.13, a gain of $18.44, or 17.11%, on high volume.  Posco Holdings Inc ADR gets a Sentiment Score of Very Bullish from InvestorsObserver and receives an average analyst recommendation of Buy with a price target of $77.40. Posco

Basic Materials Stocks Moving Monday: PKX, ELBM, REMRF, FRD, CTGO, TMC, LTHM, PPTA

For The Electric Vehicle Industry, The Future Is Sodium

AMRS

ASTLW

BHIL

CTGO

ELBM

LTHM

MEEEF

PPTA

REMRF

STLA

Press Releases

Greenhouse Emissions Study Validates Low Carbon Great Atlantic Salt Project

Atlas Salt Inc. Announces Submission of Project Registration for the Great Atlantic Salt Project Under the Newfoundland and Labrador Environmental Protection Act

Atlas Salt Inc. Announces Update on Registration Under Environmental Protection Act

TSXV:SALT

Atlas Salt